Jennifer Dimitroff, NP
Acute Care · Indianapolis, INNPI 1922731561
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,769 of the $2,811 with a category attached, or 62.9%. 16 manufacturers reported payments, led by Atricure, Inc. at 54.6% of the total. Reporting peaked in 2023 at $1,880 and has fallen 88.6% since, to $214 in 2025.
Across 38 payments — averaging $73.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- Abiomed$397
- Abbott$321
- Getinge USA Sales, LLC$170
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$62
- Edwards Lifesciences$61
- plus $265 from 10 others
What the payments were for
- Travel & lodging$1,04237%
- Food & beverage$1,76963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 10 | $1,534 |
| Abiomed | 6 | $397 |
| Abbott | 2 | $321 |
| Getinge USA Sales, LLC | 3 | $170 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $62 |
| Edwards Lifesciences | 3 | $61 |
| Merck | 2 | $53 |
| AstraZeneca | 2 | $40 |
| W. L. Gore & Associates, Inc. | 1 | $32 |
| Biomerieux Inc | 1 | $28 |
| Novo Nordisk | 1 | $27 |
| Bridgebio Pharma, Inc. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Bolton Medical Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,811 in reported general payments places this provider in the 85th percentile of 240 acute care providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 14 | $153 |
| Oxycodone Hcl | 24 | $150 |
| Amiodarone Hcl | 14 | $109 |
| ClopidogrelClopidogrel Bisulfate | 16 | $108 |
| Atorvastatin Calcium | 17 | $81 |
| Metoprolol Tartrate | 22 | $52 |
| Klor-Con M20Potassium Chloride | 15 | $29 |
| Furosemide | 22 | $15 |
Paid to pharmacies, not to this prescriber.
Other acute care in Indianapolis
- Lauren ArmingtonIndianapolis$7K
- Ashley HillIndianapolis$7K
- Rebecca DavidhizarIndianapolis$3K
- Jennifer JimenezIndianapolis$3K
- Lisa SimsIndianapolis$3K
- Kylie BeutlerIndianapolis$2K
- Alexis SmithIndianapolis$2K
- Katelyn PorterIndianapolis$2K
- Rebecca CobbIndianapolis$2K
- Jennifer BrowerIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.